Korean Journal of Family Medicine (가정의학회지)

The Korean Academy of Family Medicine (대한가정의학회)
권호 표지

The Association of Nonalcoholic Fatty Liver Disease with Metabolic Syndrome

종합검진 수진자에서 비알콜성 지방간과 대사 증후군의 연관성

Kim, Su-Yun;Lee, Hong-Soo;Lee, Sang-Hwa;Kim, Hai-Lim;Oh, Young-A;Sim, Kyung-Won
김수연;이홍수;이상화;김혜림;오영아;심경원

  • Published : 20070900
⟨ Previous Next ⟩

Abstract

The Association of Nonalcoholic Fatty Liver Disease with Metabolic SyndromeSu Yun Kim, M.D., Kyung Won Shim, M.D.†, Hong Soo Lee, M.D., Sang Hwa Lee, M.D., Hai Lim Kim, M.D., Young A Oh, M.D. Background: Recently, the diagnosis of non-alcoholic fatty liver disease (NAFLD) has been made more frequently, as the use of ultrasonography on health screening has been on the rise. The aim of this study was to elucidate the relationship between NAFLD and the metabolic syndrome defined by NCEP-ATP III criteria. Methods: A total of 1,675 subjects, who attended for routine physical check‐ups, were screened. Among those, 401 subjects were selected after excluding the subjects with either significant alcohol consumption, evidence of viral or toxic hepatitis, significant liver or renal dysfunction, or overt thyroid disease. NAFLD was diagnosed if the subjects had a “bright liver” on ultrasonographic examination. The diagnosis of metabolic syndrome was made according to the criteria of NCEP-ATP III established in 2001. Results: The prevalence of NAFLD was 27.2%. Blood pressure, body weight, body mass index, waist circumference, and serum levels of total cholesterol, triglyceride, fasting glucose and liver enzymes were higher among the subjects with NAFLD than the control. The prevalence of obesity, IFG/DM, dyslipidemia and hypertension was higher in the NAFLD group. The prevalence of the metabolic syndrome was 19.2%, which was higher in the NAFLD group than the control group. The odds ratio of NAFLD for the metabolic syndrome was 6.458 (95% C.I. 3.178∼13.124). Conclusion: NAFLD was closely associated with the metabolic syndrome regardless of the presence of obesity. (J Korean Acad Fam Med 2007;28:667-674)

연구배경: 최근 종합 검진센터에서 복부 초음파 검사율이 증가하면서 비알콜성 지방간의 발견 빈도가 증가하고 있는 추세이다. 비만, 제2형 당뇨병, 이상지질혈증과 연관성이 알려진 비알콜성 지방간의 대사적 특징을 알아보고, 대사 증후군과의 연관성을 분석하고자 하였다. 방법: 2003년 11월부터 2004년 1월까지 3개월간 일개 대학병원 종합 건강검진센터를 방문한 35세 이상의 성인 1,675명 중, 1주일에 40 g 이상의 음주력이 있거나 바이러스성, 독성 간염의 병력이 있는 경우를 제외한 401명을 대상으로, 신체 계측, 혈액 검사, 복부 초음파를 실시하였다. 먼저, 비알콜성 지방간의 유병률 및 ATP III, 아시아 태평양 지역 복부비만 기준에 따른 대사 증후군의 유병률을 알아보고, 로지스틱 회귀분석을 이용해 대사 증후군에 대한 비알콜성 지방간의 교차비를 산출하였다. 결과: 비알콜성 지방간의 유병률은 27.2%였고, 이들 환자군에서 대조군보다 혈압, 체중, 체질량 지수, 허리둘레와 총콜레스테롤, 중성지방, 공복혈당, 간 효소 수치가 의미 있게 높았으며 고밀도 지단백은 의미 있게 낮았다. 또한 환자군에서 비만, 당대사 이상, 이상지질혈증, 고혈압의 유병률이 더 높았다. 대사 증후군의 전체 유병률은 19.2%였고 비만군과 비비만군에서 비알콜성 지방간이 있는 경우 대사 증후군의 유병률이 높았다. 대사 증후군에 대한 비알콜성 지방간의 교차비는 6.458 (95% C.I. 3.178∼13.124)이었다. 결론: 비알콜성 지방간은 비만 유무에 상관없이 대사 증후군과 밀접한 연관성이 있다.

Keywords

References

  1. Ludwig J, Viaggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis. Mayo Clinic experience with an hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8
  2. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med 1997;126:137-45 https://doi.org/10.7326/0003-4819-126-2-199701150-00008
  3. Falchuk FR, Fiske SC, Haggitt RC, Federman M, Trey C.ㅡPericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 1980;78:535-41
  4. Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis 1986;8:283-98
  5. Bode JC. Nonalcoholic fatty liver disea [letter]. N Engl J Med 2002;347(10):768-9 https://doi.org/10.1056/NEJM200209053471018
  6. Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 2002;6(2):399-420 https://doi.org/10.1016/S1089-3261(02)00002-8
  7. Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine 1962;41:249-76 https://doi.org/10.1097/00005792-196209000-00003
  8. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.Hepatology 1990;12:1106-10 https://doi.org/10.1002/hep.1840120505
  9. Eriksson S, Eriksson KF, Bondesson L. Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand 1986;220:83-8
  10. 윤기석, 백승호, 신은수, 박혜순. 지방간 환자와 관련된 요인. 가정의학회지 1997;18:1426-35
  11. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80 https://doi.org/10.1002/hep.1840110114
  12. Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-8 https://doi.org/10.1016/0046-8177(89)90249-9
  13. Bacon BR, Faragvash MJ, Janny CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an espanded clinical entity. Gastroenterology 1994;107:1103-9 https://doi.org/10.1016/0016-5085(94)90235-6
  14. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001;50:1844-50 https://doi.org/10.2337/diabetes.50.8.1844
  15. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-5 https://doi.org/10.1016/S0002-9343(99)00271-5
  16. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999;18:353-8 https://doi.org/10.1016/S0261-5614(99)80015-6
  17. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287: 356-9 https://doi.org/10.1001/jama.287.3.356
  18. Meigs JB. Epidemiology of the metabolic syndrome, 2002. Am J Manag Care 2002;8 Suppl 11:283-93
  19. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999;84:1513-7 https://doi.org/10.1210/jc.84.5.1513
  20. 김용성. 비알콜성 지방간과 대사증후군. 대한내분비학회지 2002;17:460-4
  21. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: 2486-97 https://doi.org/10.1001/jama.285.19.2486
  22. WHO. The Asia-Pacific perspective: redefining obesity and its treatment. 2000. Geneva
  23. Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in detection of hepatic fibrosis and steatosis. Br Med J 1986;292:13-5 https://doi.org/10.1136/bmj.292.6512.13
  24. Par\'{e}s A, Tresserras R, Núñez I, Cerralbo M, Palana P, Massip A, et al. Prevalence and risk factors for fatty liver in presumably healthy men. Med Clin (Barc) 2000;114:561-5 https://doi.org/10.1016/S0025-7753(00)71364-9
  25. Clark JM, Diehl AM, Brancati FL. Nonalcoholic fatty liver disease and the risk of type 2 diabetes in the United States. Diabetes 2001;50 Suppl 2:38-9
  26. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1998;27:142-9
  27. 송광식, 이기영, 서찬종, 김홍규, 박혜영, 강운호. 비알콜성 지방간과 관련된 인자들에 대한 연구[초록]. 대한당뇨병학회지 2000
  28. Okita M, Hayashi M, Sasagawa T, Takagi K, Suzuki K, Kinoyama S, et al. Effect of a moderately energy-restricted diet on obese patients with fatty liver. Nutrition 2001;17:542-7 https://doi.org/10.1016/S0899-9007(01)00543-3
  29. Morimoto M, Hagbjörk AL, Nanji AA, Ingelman-Sundberg M, Lindros KO, Fu PC, et al. Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 1993;10:459-64 https://doi.org/10.1016/0741-8329(93)90065-V
  30. Drenick EJ, Simmons F, Murphy JF. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 1970;282:829-34 https://doi.org/10.1056/NEJM197004092821502
  31. Contos MJ, Sanyal AJ. The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol 2002;9:37-51 https://doi.org/10.1097/00125480-200201000-00005
  32. Assy N, Kaita K, Mmin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000;45:1929-34 https://doi.org/10.1023/A:1005661516165
  33. 김형진, 김대중, 김수경, 김세화, 이유미, 안철우 등. 한 국 성인에서 비알콜성 지방간의 중증도에 따른 대사이상의 특징. 대한내분비학회지 2002;17(4):514-24
  34. 김홍규, 서찬종, 윤효중, 황요하, 이기영, 박혜영 등. 비 알콜성 지방간과 대사성 질환들과의 연관성. 대한내분비학회지 2002;17(4):526-33
  35. 김성훈. Genetics of Metabolic Syndrome. 대한비만학회지 2004;13:83-6
  36. 이광은, 김유미, 강은석, 김혜진, 정혜원, 이시훈 등. 비비만인에서 발견되는 비알콜성 지방간의 대사적 의미.대한내과학회지 2002;63(5):488-95
  37. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94 https://doi.org/10.2337/diacare.14.3.173
  38. Bjorntorp P. Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev 1988;4:615-22 https://doi.org/10.1002/dmr.5610040607
  39. Day CP, James OF. Steatohepatitis: a tale of two 'hits'? Gastroenterology 1998;114:842-5
  40. Foster CJ, Weinsier RL, Birch R, Norris DJ, Bernstein RS, Wang J, et al. Obesity and serum lipids: an evaluation of the relative contribution of body fat and fat distribution to lipid levels. Int J Obes 1987;11(2):151-61
  41. Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after lap-band surgery. Obes Res 2002;10(9):903-10 https://doi.org/10.1038/oby.2002.124
  42. Tremblay AJ, Després JP, Piché ME, Nadeau A, Bergeron J, Alméras N, et al. Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism 2004;53(3):310-7 https://doi.org/10.1016/j.metabol.2003.10.011